Subcutaneous C1 Inhibitor for Long-term Prophylaxis of Hereditary Angioedema: A Real-life Experience

20230 citationsJournal Articlediamond Open Access

Authors

Krasimira Baynova · Hospital Universitario Virgen del Rocío

Stefan Cimbollek · Hospital Universitario Virgen del Rocío

J. Quiralte · Hospital Universitario Virgen del Rocío

Rut Ayerbe García · Hospital Universitario Virgen del Rocío

J M Lucena · Hospital Universitario Virgen del Rocío

Eva Lasa Luaces · Biogipuzkoa Health Research Institute

M A Lara Jiménez

Abstract

Supplemental material 1. Basal characteristics of patients.C1-C1-INH, C4 and C1 INH activity values before SC C1INH l LTP.On demand treatment and LTP in the previous year of the use of SC C1INH.Frequency and severity of attacks before use of SC C1INH LTP.

Topics & Keywords

Coagulation, Bradykinin, Polyphosphates, and Angioedema Hemophilia Treatment and Research

UN Sustainable Development Goals

Zero hunger

Publication Details

Published in: Journal of Investigational Allergology and Clinical Immunology

Volume 34, Issue 3, pp. 198-199

DOI: 10.18176/jiaci.0948

Field-Weighted Citation Impact: 0.00